Induction gemcitabine in standard dose or prolonged low-dose with cisplatin followed by concurrent radiochemotherapy in locally advanced non-small cell lung cancer: a randomized phase II clinical trial

Induction gemcitabine in standard dose or prolonged low-dose with cisplatin followed by concurrent radiochemotherapy in locally advanced non-small cell lung cancer: a randomized phase II clinical trial

Background. The optimal combination of chemotherapy with radiation therapy for treatment locally advanced non-small cell lung cancer (NSCLC) remains an open issue. This randomized phase II study compared gemcitabine in two different schedules and cisplatin - as induction chemotherapy, followed by ra...

Full description

Bibliographic Details
Main Authors: Vrankar Martina, Zwitter Matjaz, Bavcar Tanja, Milic Ana, Kovac Viljem
Format: Article
Language:English
Published: Sciendo 2014-12-01
Series:Radiology and Oncology
Subjects:
induction chemotherapy
gemcitabine
non-small cell lung cancer
radiation therapy
concurrent chemoradiation
randomized clinical trial
Online Access:https://doi.org/10.2478/raon-2014-0026

Internet

https://doi.org/10.2478/raon-2014-0026

Similar Items